Patent · US Active

Use of potassium hydroxide in the treatment of actinic keratosis

US11045494B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

Infectopharm Arzneimittel und Consilium GmbH · DE

Inventors

Thomas Wimmer · Rosenheim, DE
Bertil Wachall · Hemsbach, DE
Philip Zoeller · Darmstadt, DE
Alessandro Giunta · Roma, IT

Key dates

Filing date	Jul 10, 2015
Grant date	Jun 29, 2021
Priority date	—
Expiry date	Jul 10, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2300/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An agent in the form of potassium hydroxide (KOH) in a pharmaceutically acceptable composition is used in the dermal treatment of actinic keratosis. The composition may be an aqueous alkaline solution of potassium hydroxide and topically applied to the skin or on the scalp, within the face, the neck, the nose, as well as on the bosom.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.